Geron Extends $250 Million Loan Facility Terms With Pharmakon Funds

Reuters

Jan 06

Geron Extends $250 Million Loan Facility Terms With Pharmakon Funds

Geron Corporation has entered into a first amendment to its existing loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership, investment funds managed by Pharmakon Advisors, LP, with BioPharma Credit PLC serving as collateral agent. The amended agreement maintains a five-year senior secured term loan facility of up to $250 million, divided into three tranches: a $125 million Tranche A loan funded in November 2024, a $75 million Tranche B loan available at Geron's option, and a $50 million Tranche C loan contingent on achieving a specified RYTELO™ revenue milestone. The amendment extends the deadline for requesting Tranche B and C loans from December 31, 2025, to July 30, 2026, and pushes the makewhole date from November 1, 2026, to May 1, 2027. All other terms of the loan agreement remain unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geron Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-003388), on January 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2601993228"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2601993228\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2601993228?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-06 19:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601993228","market":"fut","top_or_hot":-1,"title":"Geron Extends $250 Million Loan Facility Terms With Pharmakon Funds","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Geron Extends $250 Million Loan Facility Terms With Pharmakon Funds\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Geron Corporation has entered into a first amendment to its existing loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership, investment funds managed by Pharmakon Advisors, LP, with BioPharma Credit <a href=\"https://laohu8.com/S/PLC\">PLC</a> serving as collateral agent. The amended agreement maintains a five-year senior secured term loan facility of up to $250 million, divided into three tranches: a $125 million Tranche A loan funded in November 2024, a $75 million Tranche B loan available at Geron's option, and a $50 million Tranche C loan contingent on achieving a specified RYTELO™ revenue milestone. The amendment extends the deadline for requesting Tranche B and C loans from December 31, 2025, to July 30, 2026, and pushes the makewhole date from November 1, 2026, to May 1, 2027. All other terms of the loan agreement remain unchanged.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geron Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-003388), on January 06, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Geron Extends $250 Million Loan Facility Terms With Pharmakon Funds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeron Extends $250 Million Loan Facility Terms With Pharmakon Funds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-06 19:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Geron Extends $250 Million Loan Facility Terms With Pharmakon Funds\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Geron Corporation has entered into a first amendment to its existing loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership, investment funds managed by Pharmakon Advisors, LP, with BioPharma Credit <a href=\"https://laohu8.com/S/PLC\">PLC</a> serving as collateral agent. The amended agreement maintains a five-year senior secured term loan facility of up to $250 million, divided into three tranches: a $125 million Tranche A loan funded in November 2024, a $75 million Tranche B loan available at Geron's option, and a $50 million Tranche C loan contingent on achieving a specified RYTELO™ revenue milestone. The amendment extends the deadline for requesting Tranche B and C loans from December 31, 2025, to July 30, 2026, and pushes the makewhole date from November 1, 2026, to May 1, 2027. All other terms of the loan agreement remain unchanged.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geron Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-003388), on January 06, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK5078","symbol_name":"资产管理与托管银行","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL30LQxT:1","article_id":"2601993228","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601993228","pubTimestamp":1767697453,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Geron Corporation has entered into a first amendment to its existing loan agreement with BioPharma Credit Investments V  LP and BPCR Limited Partnership, investment funds managed by Pharmakon Advisors, LP, with BioPharma Credit PLC serving as collateral agent. The amended agreement maintains a five-year senior secured term loan facility of up to $250 million, divided into three tranches: a $125 million Tranche A loan funded in November 2024, a $75 million Tranche B loan available at Geron's option, and a $50 million Tranche C loan contingent on achieving a specified RYTELO revenue milestone. The amendment extends the deadline for requesting Tranche B and C loans from December 31, 2025, to July 30, 2026, and pushes the makewhole date from November 1, 2026, to May 1, 2027. All other terms of the loan agreement remain unchanged.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK5078":"资产管理与托管银行","BK4139":"生物科技","BPCR.UK":"BIOPHARMA CRED.","GERN":"杰龙"},"translate_title":"Geron与Pharmakon Funds延长2.5亿美元贷款期限","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GERN":0.9,"BPCR.UK":0.9},"content_text":"Geron Extends $250 Million Loan Facility Terms With Pharmakon Funds\n    \n\n        Geron Corporation has entered into a first amendment to its existing loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership, investment funds managed by Pharmakon Advisors, LP, with BioPharma Credit PLC serving as collateral agent. The amended agreement maintains a five-year senior secured term loan facility of up to $250 million, divided into three tranches: a $125 million Tranche A loan funded in November 2024, a $75 million Tranche B loan available at Geron's option, and a $50 million Tranche C loan contingent on achieving a specified RYTELO™ revenue milestone. The amendment extends the deadline for requesting Tranche B and C loans from December 31, 2025, to July 30, 2026, and pushes the makewhole date from November 1, 2026, to May 1, 2027. All other terms of the loan agreement remain unchanged.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geron Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-003388), on January 06, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}